You just read:

QED Therapeutics Presents Data for Infigratinib in Cholangiocarcinoma in Late Breaking Abstract at the European Society of Medical Oncology 2018 Congress

News provided by

QED Therapeutics

Oct 19, 2018, 10:50 ET